天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片
Hubei Moco Chemical Co., Ltd.??? ?? ??? ?????.
?? ?:
Hubei Moco Chemical Co., Ltd.
??:
-18627753421
???:
3001051413@qq.com
??:
China
URL:
http://www.molcoo.com/
? ?? ?:
19375
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
?? ????
Valsartan Methyl Ester
2-???????
54765-14-9
C7H7NO
Noradrenaline Impurity 40
5-???-2-????????
884494-57-9
C6H3ClFNO2
1,3-dimethyl-26-nitrosourea
2706-56-1
C7H10N2
Tofacitinib Citrate
2,4,6-?????-1,3,5-????
877-89-4
C6H9N3O3
(R)-Amlodipine
6921-28-4
C6H7N
N-Nitroso Furosemide
58306-30-2
C20H22N4O6S
2-hydroxy-35-(methylthio)butanamide
112886-56-3
C21H25ClFN3O3
Ezetimibe (SSR)-Isomer
1401584-94-8
C6H8N2O3
Tofacitinib Impurity FD+DX
2,3,4,6-???-O-???-β-D-??????? ?????????
14152-97-7
C15H19NO9S
Vitamin B6 Impurity 82
1120-28-1
C21H42O2
Noradrenaline Impurity 46
L-????-1,5-??
52153-09-0
C6H10O6
Nintedanib Impurity 54
N-???????
2142-01-0
C15H11NO2
Tofacitinib Impurity FD+DX
55453-87-7
C16H12O4
Fulvestrant Impurity I
1297537-33-7
C19H17ClN6O2
Cilnidipine Impurity 35
15312-11-5
C5H9NO3S
Phthalamic Acid
4-???-N1-????-1,2-???
59681-66-2
C7H9ClN2
Lactate tetramer
70779-06-5
C28H47NO5
2-hydroxy-29-(methylthio)butanamide
2095840-86-9
C7H6IN5
Linagliptin Impurity CD10113
?????3-(3-??????????)???????
21172-43-0
C11H13F3O3S
DL-Methionine Sulfoxide
??
89-83-8
C10H14O
Fulvestrant Impurity I
D-????,γ-??
1198-69-2
C6H10O6
Lactate tetramer
2741194-01-2
C23H26N2O8S
Phthalamic Acid
3103-17-1
C21H26O4
Baricitinib Impurity I
2787819-29-6
C16H10ClFN2O3
N-Nitroso Furosemide
2932441-73-9
1,3-dimethyl-32-nitrosourea
2-?????????,1-???-,(2S)-(9CI)
700376-84-7
C7H10N2O
Varenicline Impurity D
????????????
170571-00-3
C17H14F3N3O3S
Cilnidipine Impurity 38
2433-97-8
C24H48O2
(R)-Amlodipine
22204-24-6
C34H30N2O6S
Vitamin B6 Impurity 81
92850-02-7
C15H15N
1,3-dimethyl-31-nitrosourea
885045-90-9
C33H29ClN4O2
DL-Methionine Sulfoxide
N-????????
25779-79-7
C8H14N2O5S2
Tofacitinib Impurity FD+DX
S-????
150566-71-5
C26H31ClN2O8S
Vitamin B6 Impurity 83
racDes(????????)-2-????????????????
1215342-36-1
C19H33NO5
Baricitinib Impurity I
????HCL
700361-47-3
C22H19ClN6
Varenicline Impurity D
1507299-93-5
C9H12O4S
Rosuvastatin EP Impurity A
p-???????
122-00-9
C9H10O
Ezetimibe (SSR)-Isomer
2047-49-6
C6H4N2O4
N-Nitroso Furosemide
17-???-10-??-3,6,12,15-?????-9-???????
1143516-05-5
C12H24N2O7
Vitamin B6 Impurity 85
3-??????2-?????????
54527-68-3
C6H9ClO3
Linagliptin Impurity CD10121
936623-90-4
C48H58N6O8
Phthalamic Acid
301-00-8
C19H32O2
Tofacitinib Impurity FD+DX
??????EP???E
923035-05-6
C13H20N2O2
N-Nitroso Furosemide
4515-18-8
C6H10N2O3
Fulvestrant Impurity I
1118767-16-0
C43H79N3O13
Valsartan Methyl Ester
?????
1369764-02-2
C22H20F2N4O2
(R)-Amlodipine
4-???-1-(3-??????)-1-????
3110-52-9
C10H10ClFO
Rosuvastatin EP Impurity A
1675248-18-6
C18H25N5O3
Nintedanib Impurity 57
1938090-31-3
C21H27ClO7
Deubutafrazine Impurity
107007-95-4
C17 H22 N4 O
Nintedanib Impurity 56
5-O-??????
80681-42-1
C16H18O5
(R)-Amlodipine
2101302-47-8
C8H12N2O2S
Ezetimibe (SSR)-Isomer
133481-09-1
C9H13NO2
Tofacitinib Impurity FD+DX
526204-10-4
C17H18FN3O3
1,3-dimethyl-34-nitrosourea
272778-13-9
C30H37F2NO3Si2
1,3-dimethyl-30-nitrosourea
?????
75-12-7
CH3NO
DL-Methionine Sulfoxide
376592-93-7
C13H11NO3
Tofacitinib Citrate
82956-11-4
C21H25N5O8S2
Vitamin B6 Impurity 84
138884-14-7
C17H32N4O7
Fulvestrant Impurity I
?? ???? ?
112-39-0
C17H34O2
Fulvestrant Impurity I
127472-42-8
C18H24N4O
Rosuvastatin EP Impurity A
2285346-38-3
Fulvestrant Impurity I
9-???????
91421-43-1
C20H17N3O4
Tofacitinib Impurity FD+DX
1179031-47-0
C12H14ClN
Valsartan Methyl Ester
1416134-63-8
C16H20N2O4
Tofacitinib Citrate
1632287-34-3
C23H27ClO7
Rosuvastatin EP Impurity A
1-??-1H-???-3-??????
129137-93-5
C9H9N3O
(R)-Amlodipine
Des(????????)?????
62572-93-4
C13H21NO3
Baricitinib Impurity I
Granisetron???C
160177-67-3
C17H22N4O
Ezetimibe (SSR)-Isomer
9-????????
19685-10-0
C21H18N2O5
Tofacitinib Citrate
624-84-0
CH4N2O
N-Nitroso Furosemide
?? ???????
929-77-1
C23H46O2
Noradrenaline Impurity 47
(3R,6R)-3,6-??[(?????)??]-2,5-??????
16337-02-3
C6H12N4O4
Lactate tetramer
2,4-??????-3,3-?????????
10232-92-5
C6H11NO2
Tofacitinib Citrate
1297537-41-7
C13H13ClN4
2-hydroxy-34-(methylthio)butanamide
?? ??????
112-61-8
C19H38O2
Nintedanib Impurity 59
3-????????2-??????????????????
87330-70-9
C8H11ClN2O2
Vitamin B6 Impurity 86
?????????E
67950-95-2
C9H14O4
Varenicline Impurity D
2055343-42-3
C21H29N6O7P
Ezetimibe (SSR)-Isomer
1100676-15-0
C29H42NO7+
Linagliptin Impurity CD10119
112886-58-5
C21H25ClFN3O3
Rosuvastatin EP Impurity A
2356153-95-0
C17H14F3N3O3S
Baricitinib Impurity I
2407645-49-0
C19H19ClN6O2
Noradrenaline Impurity 44
2469242-96-2
C22H23ClF3N
Valsartan Methyl Ester
62971-57-7
C7H5Cl2NO4S
Tofacitinib Citrate
1298086-28-8
C22H25ClO8
Cilnidipine Impurity 41
N-?????????
65445-62-7
C6H10N2O3
DL-Methionine Sulfoxide
2733250-84-3
C13H21NO5S
Cilnidipine Impurity 37
2814571-35-0
C57H49F4N13O9S2
Linagliptin Impurity CD10117
1346601-75-9
C17H29NO4
Valsartan Methyl Ester
1,2?????????
2876-08-6
C9H10N2
Rosuvastatin EP Impurity A
1966991-73-0
C13 H12 F2 N4 O
Vitamin B6 Impurity 79
2410284-89-6
C22H30N6O2
Noradrenaline Impurity 41
2408495-96-3
C29H40O7
Ezetimibe (SSR)-Isomer
775304-64-8
C16H11FN2O3
N-Nitroso Furosemide
2476465-06-0
C17H19NO5S
Varenicline Impurity D
2786607-23-4
C16H12N2O3
Linagliptin Impurity CD10115
917389-29-8
C30H30F4N4O4
2-hydroxy-33-(methylthio)butanamide
851440-19-2
C26H34FN3O6S
Tofacitinib Citrate
345949-37-3
C13H11ClO
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
Copyright 2019 ? ChemicalBook. All rights reserved